Member Info for smithfields

'Doesn't look good as the cash runs out ...'

What's the point of raising more money......if the company is just standing still and not going anywhere?....It's just money down the plug hole.

A bit more media cover..

https://www.msn.com/en-gb/health/other/earliest-signs-of-cancer-can-be-found-in-the-blood/ar-AA1GRB8c?ocid=hpmsn&cvid=685b26362e254f5c8271e9e44442731d&ei=13

Https://www.msn.com/en-gb/health/other/cancer-treatment-revolution-on-the-horizon-says-leading-doctor/ar-AA1IxcH6?ocid=hpmsn&cvid=344898c88f794fd8a5050a8558dbabf8&ei=25

No point in a cash raise......might as well just take the company out...

This Government would rather see older patients die, ie 'The Assisted Dying'Bill' than pay to have patients treated.....that way they can kick IHT into play...ie; money coming as opposed to money going out.

https://www.bbc.co.uk/news/articles/c7v6g9q6rjqo#:~:text=The%20health%20assessment%20body%2C%20NICE,will%20follow%20this%20guidance%20too.

Https://businessplus.ie/news/astrazeneca-mulls-us-listing/

Just a passing thought.......Let's assume that 'Big Pharma' are interested in AGL's FDA Approved Parsotix system.....and also know that they're running low on cash....Looking a this from Big Pharma's perspective....and knowing that AGL are low on cash...allow them to run low, with the possibility of a cash raise. Allow them to issue a swathe of shares at the lower rate....then step in and take up the whole new issue ..thereby immediately , due to their involvement, increases the SP.....so, in effect, gain a large holding in AGL....for free.....As I said....just a thought.

(One of the ways AGL can avoid falling into this 'trap'...is to create a bidding war for the Parsortix system.....if it's worth fighting for?)

On the LSE thread...'goosed' managed to incorporate NHS ten timers into his post.....I'll wait and see.

Gordon.....With the SP in uncharted waters..... where do we go from here?.In short, how is AN going to get out of this hole?

'Its costs are 1 million a month'. ....(It now costs 1 million a month minus two directors salaries)

Related item..

https://pharmaphorum.com/news/asco-25-enhertu-bids-earlier-use-her2-breast-cancer

Https://www.msn.com/en-gb/health/medical/revolutionary-dna-blood-test-to-offer-thousands-in-england-tailored-cancer-care/ar-AA1FJq76?ocid=hpmsn&cvid=34fae5a78b8348f88556ff74138ae557&ei=25

It makes one wonder...'With the cash burn rate, what was the point of going to the expense of a a 'lack-lustre' presentation with no 'meat on the bones' that had an adverse effect on the sp? (that AN must have realised would be the outcome?)

Oilheadgame......love your enthusiasm with respect to the presentation....I'm glad it wasn't just a'polish-the-turd' lecture.

'As an investor here who recently bought in sub 9p ...'

If this is cr+p, as you keep telliing us.,...why did you buy at all?

Https://www.msn.com/en-gb/money/other/astrazeneca-doubles-down-on-us-manufacturing-amid-tariff-threat/ar-AA1DPNyC?ocid=hpmsn&cvid=3d3d5e8c09924312a38a2c396008c46a&ei=117

Related Topic

https://www.msn.com/en-gb/health/other/buy-our-cancer-drugs-or-jobs-will-go-overseas-astrazeneca-warns/ar-AA1DQzvP?ocid=hpmsn&cvid=32c10e0a8993434bade454729f86ba97&ei=83

AGL would have to have been granted permission to use Ilumina's reference....which could be a positive sign.

Tarrif ref..

“The U.S. alone will struggle to build competitive manufacturing and strategic autonomy,” said its director general, Adrian van den Hoven.

“The knock on effect of tariffs will be to drive up costs even higher for patients'

https://www.politico.eu/person/adrian-van-den-hoven/

(personal comment....By the time Pharma' get up and running in the U.S....Trump will have been long gone)

Https://www.qmul.ac.uk/research/featured-research/the-pinprick-that-improves-cancer-diagnosis-rapid-blood-test-brings-prostate-cancer-hope/#:~:text=Accuracy%20and%20speed%20of%20diagnosis,before%20spreading%20around%20the%20body.